Thyroid Cancer Clinical Trial
Official title:
The Relationship of Modified Cormack Lehane Scores Between Preoperative Awake Flexible Fiberoptic Laryngoscopy and Intraoperative Direct Laryngoscopy in Thyroidectomies, a Prospective, Clinical Study
Nowadays, 5-step modified Cormack-Lehane scoring (MCL) system is frequently used in the
observation of laryngeal structures by direct laryngoscopy.
Upper airways with flexible fiberoptic laryngoscopy are routinely evaluated in patients who
are predicted to be difficult intubation, who have undergone head or neck surgery previously
and who require vocal cords to be evaluated preoperatively. During this examination patients
are awake; so the upper airway and the muscles in the base of the mouth have normal tonus and
airway reflexes are active. When general anesthesia is applied to the same patients during
direct laryngoscopy, the laryngeal view may not be as clear as awake flexible fiberoptic
laryngoscopy, since a tonus loss occurs in the muscles after general anesthesia.
The aim of the study is to investigate the relationship between preoperative awake flexible
fiberoptic laryngoscopy performed by ear- nose- throat (ENT) physicians in patients
undergoing total thyroidectomy, and the MCL score during direct laryngoscopy after general
anesthesia in the same patients. Thus, investigators would like to determine the reliability
of airway evaluation with preoperative awake flexible fiberoptic laryngoscopy in predicting
intubation conditions during tracheal intubation under general anesthesia.
In daily practice, the upper airway evaluation is performed by the ENT physician with
flexible fiberoptic laryngoscopy while the patients are awake one day before thyroidectomy.
This evaluation will be done by the same ENT physician (EDG). Each patient will be kept in
the neutral position and at the level of soft palate, the larynx will be observed by the
flexible fiberoptic laryngoscopy and the laryngeal view and MCL score of these patients will
be recorded.
The same patients will be taken to the preoperative care unit on the morning of operation and
20 G intravenous cannulation will be performed on the left hand. Patients' neck circumference
and Mallampati score and presence of obstructive sleep apnea syndrome will be recorded.
Patients will be taken to the operation theatre and standard monitoring will be performed
consisting of electrocardiography (ECG), non-invasive blood pressure (BP) and peripheral O2
saturation. After induction of general anesthesia, the same anesthesiologist (CAB) will
perform direct laryngoscopy by using Macintosh laryngoscope the MCL score will be recorded.
The anesthesiologist will not know the MCL score that was previously evaluated by ENT
physician during awake fiberoptic flexible laryngoscopy. Female and male patients will be
intubated orotracheally with 7.5-8 internal diameter endotracheal tube, respectively. It will
be recorded if the backward, upward, right, lateral pressure Maneuver (BURP) is applied
during intubation. The maintenance of general anesthesia will be provided with 2% Sevoflurane
in a 40% oxygen-air mixture.
After thyroidectomy is over patients will be extubated. The primary endpoint of the study was
to evaluate the relationship between the MCL score, which was evaluated preoperatively, and
the MCL score during direct laryngoscopy during intraoperative general anesthesia in awake
patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05774535 -
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
|
||
Withdrawn |
NCT04224792 -
Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors
|
N/A | |
Completed |
NCT01728623 -
A Study of E7080 in Subjects With Advanced Thyroid Cancer
|
Phase 2 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT02911155 -
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
|
||
Recruiting |
NCT05025046 -
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
|
||
Not yet recruiting |
NCT03978351 -
The Role of Midkine in Diagnosis of Thyroid Cancer
|
||
Completed |
NCT02658513 -
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
|
||
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
Withdrawn |
NCT01994200 -
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
|
Phase 1/Phase 2 | |
Terminated |
NCT01403324 -
Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
|
N/A | |
Completed |
NCT00970359 -
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
|
N/A | |
Completed |
NCT00439478 -
Dental Safety Profile of High-Dose Radioiodine Therapy
|
Phase 4 | |
Completed |
NCT00223158 -
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
|
N/A | |
Active, not recruiting |
NCT04544111 -
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
|
Phase 2 | |
Completed |
NCT04876287 -
Salivary dysfuncTion After Radioiodine Treatment
|
||
Recruiting |
NCT06073223 -
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
|
N/A | |
Recruiting |
NCT06037174 -
Comparison of Quality of Life in Patients With Differentiated Thyroid Carcinoma Undergoing Different Surgery
|
||
Recruiting |
NCT04952493 -
Anlotinib or Penpulimab in Combination With RAI for DTC
|
Phase 2 |